Maynard Um
-
-
-
-
-
-
-
Bristol-Myers Squibb Co. (BMY) PT Raised to $75 at Guggenheim
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Declares $0.63 Quarterly Dividend; 4.6% Yield
-
-
-
-
-
-
-
Bristol Myers Squibb drug reduces multiple myeloma progression risk by 52%
-
-
-
-
-
-
-
Bristol Myers Squibb gets EU approval for Sotyktu to treat psoriatic arthritis
-
-
-
-
-
-
-
Raymond James Preview Bristol-Myers Squibb Co. (BMY) Earnings: 'Our updated diluted non-GAAP EPS is $1.49 for 1Q26 '
-
-
-
-
-
-
-
A New Era in Schizophrenia Care: National Council for Mental Wellbeing and Bristol Myers Squibb Collaborate to Advance Evidence-Based Care Models
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Declares $0.63 Quarterly Dividend; 4% Yield
-
427,663 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

